期刊文献+

LC-MS/MS测定人血浆中辛伐他汀及其活性代谢物的含量 被引量:6

LC-MS/MS determination of simvastatin and its active metabolite in human plasma
原文传递
导出
摘要 目的:建立人血浆中辛伐他汀及其活性代谢物辛伐他汀酸的LC-MS/MS测定方法。方法:血浆样本在酸性条件下经甲基叔丁基醚液液萃取后,以2.5 mmol.L-1醋酸铵(含0.1%甲酸)-乙腈(25∶75)为流动相,采用Inertsil ODS-3(2.1 mm×150 mm,5μm)色谱柱分离。使用电喷雾离子源以多反应监测(MRM)方式分别进行正负离子监测。辛伐他汀选用洛伐他汀作为内标,在正离子模式下检测;代谢物辛伐他汀酸选用洛伐他汀酸作为内标,在负离子模式下监测。结果:测定血浆中辛伐他汀及其代谢物辛伐他汀酸的线性范围均为0.1~20.0μg.L-1;方法回收率分别为86.1%~100.5%,91.5%~104.4%;日内精密度分别为3.2%~4.7%和4.5%~6.9%,日间精密度分别为3.6%~9.8%和2.3%~10.5%。结论:该方法简便快速、灵敏度高、重复性好,可准确的定量人血浆辛伐他汀及代谢物辛伐他汀酸的浓度,适用于辛伐他汀药代动力学研究。 Objective : To establish an LC - MS/MS method for the determination of simvastatin and its active me- tabolite (simvastatin acid)in human plasma. Methods:The acidified sample was extracted by MTBE, then separated on an Inertsil ODS -3 (2. 1 mm 150 mm,5 μm)column with 2.5 mmol . L-1 ammonium acetate(containing 0. 1% formic acid) -acetonitrile(25:75)as mobile phase. Electrospray ionization source(ESI) was applied and op- erated in multiple reactions monitoring(MRM) mode. Simvastatin was detected in positive ion mode with lovastatin as internal standard, and its active metabolite was determined in negative ion mode with lovastatin acid as internal standard. Results:The calibration curves of simvastatin and its active metabolite were linear in the range of 0. 1 - 20. 0 μg. L-1. The method recoveries were 86. 1% - 100. 5% % and 91.5% - 104. 4% ,respectively. The intra - day precisions were 3.2% -4. 7% and 4. 5% -6. 9%, respectively;the inter - day precisions were 3.6% -9. 8% and 2. 3% -10. 5%, respectively. Conclusions :The method is simple ,rapid, sensitive and reproducibility for the determi- nation of simvastatin and its metabolite in human plasma. It is suitable for the pharmacokinetic study of simvastatin.
出处 《药物分析杂志》 CAS CSCD 北大核心 2012年第9期1617-1622,共6页 Chinese Journal of Pharmaceutical Analysis
关键词 调脂药物 前体药物 辛伐他汀 辛伐他汀酸 液相色谱串联质谱法 活性代谢物 人血浆样品 血药浓度 药代动力学 临床用药监测 lipid regulating drugs precursor medicine simvastatin simvastatin acid LC - MS/MS active metabo- lite human plasma sample plasma drug concentration pharmacokinetics clinical medication monitoring
  • 相关文献

参考文献12

  • 1Shitara Y, Sugiyama Y. Pharmacokinetic and pharmacodynamic alter- ations of 3 - hydroxy - 3 - methylglutaryl coenzyme A ( I-IMG - CoA) reductase inhibitors: drug - drug interactions and interindividual differences in transporter and metabolic enzyme functions. PharmacolTher ,2006 ,112 ( 1 ) :71.
  • 2Beri A, Sural N, Mahajan SB. Non - atheroprotective effects of st- atins:a systematic review. Am J Cardiovasc Drugs ,2009,9 (6) :361.
  • 3郑金琪,郑国钢,李会林,黄豆,胡楚楚.梯度洗脱HPLC测定辛伐他汀片的含量和有关物质[J].中国药学杂志,2010,45(9):702-705. 被引量:10
  • 4Novakova L,Satinsky D, Solich P. HPLC methods for the determination of simvastatin and atorvastatin. Trend Anal Chem,2008,27 (4) :352.
  • 5江波,袁虹,许东航,周权,阮邹荣.液相色谱-电喷雾串联质谱法测定人血浆中辛伐他汀浓度[J].药物分析杂志,2007,27(6):800-804. 被引量:7
  • 6Najib NM, Idkaidek N, Adel A, et al. Pharmacokinetics and bio- equivalence evaluation of two simvastatin 40 mg tablets( simvast and zocor) in healthy human volunteers. Biopharm Drug Dispos,2003,24 (5) :183.
  • 7张成志,周远大,何海霞.辛伐他汀片人体生物等效性研究[J].中国药房,2009,20(5):354-356. 被引量:2
  • 8刘史佳,储继红,居文政,谈恒山,熊宁宁.LC-MS/MS法研究辛伐他汀片在健康人体内的药代动力学及生物等效性[J].中国临床药理学与治疗学,2006,11(7):833-836. 被引量:11
  • 9Patel BN, Sharma N, Sanyal M, et al. Simultaneous determination of simvastatin and simvastatin acid in human plasma by LC - MS/MS without polarity switch:Application to a bioequivalence study. J Sep Sci,2008,31 (2) :301.
  • 10Barrett B, HuclovO J, Borek - Dohalsky V, et al. Validated HPLC - MS/MS method for simultaneous determination of simvastatin and simvastatin hydroxy acid in human plasma. J Pharm Biomed Anal, 2006,41 (2) :517.

二级参考文献22

共引文献25

同被引文献134

引证文献6

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部